Top news of the week: 21.04.2020.
#COVID19 #biotechnology #CoronaPandemic #biospace #lifesciences #pharmaceuticals #CoronaVirus #CoronaOutbreak #Biotech #VCs
Career And Jobs
Biopharma Update on the Novel Coronavirus: April 16
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/ShAvyG8EWM
OpenBiopharma Update on the Novel Coronavirus: April 16
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
Biopharma Update on the Novel Coronavirus: April 14
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/WutGUDmo6S
OpenBiopharma Update on the Novel Coronavirus: April 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
#Biotech #VentureCapitalists are continuing efforts to launch new drug #startups despite #COVID19 disruptions. In fact, #VCs may be able to consider more new #biotech opportunities now that videoconferences have replaced travel to meetings https://t.co/QmPQHWwlFx @WSJ
OpenBiotech VCs Steer Around Covid-19 Obstacles
Investors at firms such as Atlas Venture, Third Rock Ventures, Avalon Ventures, ARCH Venture Partners and MPM Capital say they are finding ways to continue launching and building biotech ...
Biopharma Update on the Novel Coronavirus: April 17
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/acfm873y24
OpenBiopharma Update on the Novel Coronavirus: April 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 17, 2020.
Additional Update on COVID-19 Compassionate Use with Opaganib in Israel Provided by RedHill Biopharma
https://t.co/VttAR4GYDW
#news #pharma #pharmiweb
OpenAdditional Update on COVID-19 Compassionate Use with Opaganib in Israel Provided by RedHill Biopharma
All five patients have shown an improved CRP, with four of the five patients also demonstrating measurable clinical improvement, including required supplemental oxygenation and higher ...
$MRNA
"That was good enough for a 21% spike in the share price on Thursday evening, worth more than $2.6 billion in market cap as the company's valuation surged past the $15 billion mark."'
https://t.co/9VxgPbUH6C
https://t.co/9VxgPbUH6C
OpenUPDATED: BARDA bets $483M on Moderna’s Covid-19 vaccine as the biotech plots ultra-fast PhIII, recruiting 150 staffers to scale up 24/7
BARDA has agreed to gamble up to $483 million on Moderna’s clinical-stage vaccine to guard against SARS-CoV-2 — a move that will fund development through a hoped-for BLA filing for ...
Despite the gyrations of the stock market, MA #biopharma co's have raised over $600M during the past several weeks. In today's blog, @HallinanJ, Chief Business Officer, MassBio discusses the success of the MA ecosystem as we embark on the "new normal" https://t.co/1sYkgMOy9M https://t.co/6WQsUpuepH
OpenBiopharma Funding in the Age of COVID-19
We have been living in a historic time defined by a continuous stream of news that no Washington Insider could spin as positive. At the same time, we can be heartened by the industry’s ...
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma https://t.co/KQTKN7cd1R
OpenHorizon Therapeutics, United Therapeutics, Acorda Therapeutics, Exact Sciences, Harmony Biosciences, Accent Therapeutics and Boston Pharmaceuticals rounded out the top 10 honors for biopharma.
Biopharma companies all vow to help patients, but how do they fare in creating a healthy workplace environment for their employees? Roche’s Genentech, Novo Nordisk and AbbVie ranked as the ...